Hearne Michael S

Chief Financial OfficerLA JOLLA PHARMACEUTICAL CO (LJPC) · full profile →Form 4 · filed Aug 24, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
32
2 non-derivative · 30 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 22, 2022Tender(U)9.6M$6.23$59.9M0
Aug 22, 2022Disposed to issuer(D)10K$6.23$63K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 22, 2022Disposed to issuer(D)1390
Aug 22, 2022Disposed to issuer(D)1270
Aug 22, 2022Disposed to issuer(D)1720
Aug 22, 2022Disposed to issuer(D)1730
Aug 22, 2022Disposed to issuer(D)1640
Aug 22, 2022Disposed to issuer(D)3860
Aug 22, 2022Disposed to issuer(D)1690
Aug 22, 2022Disposed to issuer(D)1480
Aug 22, 2022Disposed to issuer(D)1700
Aug 22, 2022Disposed to issuer(D)2010
Aug 22, 2022Disposed to issuer(D)7280
Aug 22, 2022Disposed to issuer(D)3730
Aug 22, 2022Disposed to issuer(D)1810
Aug 22, 2022Disposed to issuer(D)5580
Aug 22, 2022Disposed to issuer(D)1860
Aug 22, 2022Disposed to issuer(D)1730
Aug 22, 2022Disposed to issuer(D)1570
Aug 22, 2022Disposed to issuer(D)79K0
Aug 22, 2022Disposed to issuer(D)1480
Aug 22, 2022Disposed to issuer(D)100K0
Aug 22, 2022Disposed to issuer(D)1690
Aug 22, 2022Disposed to issuer(D)1960
Aug 22, 2022Disposed to issuer(D)1410
Aug 22, 2022Disposed to issuer(D)1340
Aug 22, 2022Disposed to issuer(D)52K0
Aug 22, 2022Disposed to issuer(D)1470
Aug 22, 2022Disposed to issuer(D)2K0
Aug 22, 2022Disposed to issuer(D)1360
Aug 22, 2022Disposed to issuer(D)1180
Aug 22, 2022Disposed to issuer(D)1080

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-029649) within minutes of acceptance. Every field above traces to the original document. Verify it directly: